Validation of a clinical prediction scale for hospital-onset clostridium difficile infection

Journal of Clinical Gastroenterology

Volumn 48, Issue 5, 2014, Pages 419-422

  Chandra, Subhash ^a   Thapa, Rameet ^a   Marur, Surendra ^a   Jani, Niraj ^a  

^a GREATER BALTIMORE MEDICAL CENTER   (United States)

Author keywords

clinical prediction scale; Clostridium difficile infection; hypoalbuminemia

Indexed keywords

ANTIBIOTIC AGENT; BACTERIAL TOXIN; CEPHALOSPORIN DERIVATIVE; PENICILLIN DERIVATIVE; PROBIOTIC AGENT; PROTON PUMP INHIBITOR; QUINOLINE DERIVED ANTIINFECTIVE AGENT;

AGED; ANTIBIOTIC THERAPY; ARTICLE; ARTIFICIAL VENTILATION; BACTERIAL GENE; CLINICAL PREDICTION SCALE; CLOSTRIDIUM DIFFICILE INFECTION; DIAGNOSTIC TEST ACCURACY STUDY; DIARRHEA; FEMALE; HOSPITAL ADMISSION; HOSPITAL INFECTION; HUMAN; HYPOALBUMINEMIA; INFECTION RISK; LENGTH OF STAY; LONG TERM CARE; LOOSE FECES; MAJOR CLINICAL STUDY; MALE; POLYMERASE CHAIN REACTION; PREDICTION; PRIORITY JOURNAL; RATING SCALE; RISK ASSESSMENT; SENSITIVITY AND SPECIFICITY; VALIDATION STUDY; CLOSTRIDIUM INFECTIONS; CROSS INFECTION; HOSPITALIZATION; ISOLATION AND PURIFICATION; MICROBIOLOGY; MIDDLE AGED; PEPTOCLOSTRIDIUM DIFFICILE; PREDICTIVE VALUE; PROCEDURES; RECEIVER OPERATING CHARACTERISTIC; RETROSPECTIVE STUDY; RISK FACTOR; VERY ELDERLY;

AGED; AGED, 80 AND OVER; CLOSTRIDIUM DIFFICILE; CLOSTRIDIUM INFECTIONS; CROSS INFECTION; DIARRHEA; FEMALE; HOSPITALIZATION; HUMANS; LENGTH OF STAY; MALE; MIDDLE AGED; POLYMERASE CHAIN REACTION; PREDICTIVE VALUE OF TESTS; PROBIOTICS; RETROSPECTIVE STUDIES; RISK FACTORS; ROC CURVE;

EID: 84898599193     PISSN: 01920790     EISSN: 15392031     Source Type: Journal    
DOI: 10.1097/MCG.0000000000000012     Document Type: Article

References (16)

1. Lucado J, Gould C, Elixhauser A. Clostridium difficile infections (CDI) in hospital stays, 2009: statistical brief #124. Healthcare Cost and Utilization Project (HCUP) Statistical Briefs. Rockville (MD), 2012.
2. Chandra S, Jariwala U, Thapa R, et al. An observational study to report Clostridium difficile infection related hospitalization: trend over 2005-2011. Am J Gastroenterol. 2012;107:1.
3. Cohen SH, Gerding DN, Johnson S, et al. Clinical practice guidelines for Clostridium difficile infection in adults: 2010 update by the society for healthcare epidemiology of America (SHEA) and the infectious diseases society of America (IDSA). Infect Control Hosp Epidemiol. 2010;31:431-455.
4. Surawicz CM, Brandt LJ, Binion DG, et al. Guidelines for diagnosis, treatment, and prevention of Clostridium difficile infections. Am J Gastroenterol. 2013;108:478-498, quiz 499.
5. Chandra S, Kashyap R, Trillo-Alvarez CA, et al. Mapping physicians' admission diagnoses to structured concepts towards fully automatic calculation of acute physiology and chronic health evaluation score. BMJ Open. 2011;1:e000216.
6. Kim H, Jeong SH, Kim M, et al. Detection of Clostridium difficile toxin A/B genes by multiplex real-time PCR for the diagnosis of C. difficile infection. J Med Microbiol. 2012; 61:274-277.
7. Chandra S, Jariwala U, Thapa R, et al. A cohort study for the derivation and validation of a clinical prediction scale for hospital-onset Clostridium difficile infection. Can J Gastro-enterol. 2012;26:885-888.
8. Laupacis A, Sekar N, Stiell IG. Clinical prediction rules. A review and suggested modifications of methodological standards. JAMA. 1997;277:488-494.
9. Stiell IG, Wells GA. Methodologic standards for the development of clinical decision rules in emergency medicine. Ann Emerg Med. 1999;33:437-447.
10. Dubberke ER, Yan Y, Reske KA, et al. Development and validation of a Clostridium difficile infection risk prediction model. Infect Control Hosp Epidemiol. 2011;32: 360-366.
11. Chandra S, Agarwal D, Hanson A, et al. The use of an electronic medical record based automatic calculation tool to quantify risk of unplanned readmission to the intensive care unit: a validation study. J Crit Care. 2011;26: 634 e9-634 e15.
12. Soni NJ, Samson DJ, Galaydick JL, et al. Procalcitonin-guided antibiotic therapy: a systematic review and meta-analysis. J Hosp Med. 2013;8:530-540, 2012/12/28 ed, 2012.
13. Johnston BC, Ma SS, Goldenberg JZ, et al. Probiotics for the prevention of Clostridium difficile-associated diarrhea: a systematic review and meta-analysis. Ann Intern Med. 2012; 157:878-888.
14. Motzkus-Feagans CA, Pakyz A, Polk R, et al. Statin use and the risk of Clostridium difficile in academic medical centres. Gut. 2012;61:1538-1542.
15. Garey KW, Dao-Tran TK, Jiang ZD, et al. A clinical risk index for Clostridium difficile infection in hospitalised patients receiving broad-spectrum antibiotics. J Hosp Infect. 2008; 70:142-147.
16. Peled N, Pitlik S, Samra Z, et al. Predicting Clostridium difficile toxin in hospitalized patients with antibiotic-associated diarrhea. Infect Control Hosp Epidemiol. 2007;28:377-381.